title: Substance abuse and psychosis.
abstract: This article reviews the literature for the most pressing diagnostic and treatment challenges faced in working with adolescents. Diagnosing the treatment interventions required for this population involve psychoeducation, engagement of the patient and family in the treatment process, and use of antipsychotic medications. Cannabis may be a causal risk factor in psychotic illness, and data support recommendations to reduce or cease cannabis use in this population. Treatment strategies are discussed that are effective in adult patients and that may be efficacious for youth to abstain from substances after the resolution of psychotic symptoms.
authors.affiliation: Division of Child and Adolescent Psychiatry, University of Minnesota Medical School, F256/2B West, 2450 Riverside Avenue, Minneapolis, MN 55454, USA. Electronic address: morg0153@umn.edu.
authors.forename: Danielle
authors.initials: D
authors.lastname: Goerke
authors.forename: Sanjiv
authors.initials: S
authors.lastname: Kumra
mesh_terms: D000293:Adolescent; D041923:Adolescent Development / Q000187:drug effects*; D014150:Antipsychotic Agents / Q000627:therapeutic use; D002188:Cannabis / Q000009:adverse effects*; D003937:Diagnosis, Differential; D017831:Diagnosis, Dual (Psychiatry); D004198:Disease Susceptibility; D006801:Humans; D007406:Interview, Psychological; D002189:Marijuana Abuse / Q000150:complications* / Q000517:prevention & control; D010349:Patient Compliance / Q000523:psychology; D011605:Psychoses, Substance-Induced / Q000150:complications / Q000175:diagnosis / Q000628:therapy; D012307:Risk Factors; D055502:Secondary Prevention; D055815:Young Adult
chemical_list: D014150:Antipsychotic Agents
keywords: Adolescent psychosis; Cannabis and psychosis; Dual diagnosis; Substance-induced psychosis